HLA-A*02:01-POSITIVE
Clinical trials for HLA-A*02:01-POSITIVE explained in plain language.
Never miss a new study
Get alerted when new HLA-A*02:01-POSITIVE trials appear
Sign up with your email to follow new studies for HLA-A*02:01-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to receive new 'ImmTAC' cancer drug in groundbreaking trial
Disease control Recruiting nowThis is the first-ever study in people for a new drug called IMC-P115C, designed to treat advanced cancers that have a specific marker called PRAME. The main goal is to test the drug's safety and see if it causes any serious side effects when given alone or with standard treatmen…
Matched conditions: HLA-A*02:01-POSITIVE
Phase: PHASE1 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Breakthrough cancer drug trial seeks to train immune system to fight advanced tumors
Disease control Recruiting nowThis study is testing a new type of immune therapy drug called IMC-R117C for people with advanced colorectal, esophageal, gastric, or ovarian cancers. The drug is designed to help the body's own immune cells find and attack cancer cells. Researchers will test the drug alone and i…
Matched conditions: HLA-A*02:01-POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC